CrossrefInfokarte
Prevalent Sodium-Glucose Co-Transporter 2 Inhibitor Use, Baseline Laboratory Profile, and Clinical Outcomes in a Real-World Heart Failure Cohort-Uncorrected Proof
Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology · 2026 · 54 (54) · 6-6
DOI: 10.5543/tkda.2026.27385 ↗Abstract
Kein Abstract verfügbar.
EUVIMED